In silico molecular docking studies and MM/GBSA analysis of coumarin-carbonodithioate hybrid derivatives divulge the anticancer potential against breast cancer

被引:0
作者
Shridhar Veeresh Pattar
Shakeel Ahamed Adhoni
Chandrappa Mukappa Kamanavalli
Suresh Sadashiv Kumbar
机构
[1] Karnatak University,P. G. Department of Studies in Biochemistry
[2] Jain University Centre for Nano and Material Science,undefined
来源
Beni-Suef University Journal of Basic and Applied Sciences | / 9卷
关键词
Coumarin-carbonodithioate; MM-GBSA; score; Alpelisib; Binding energy; PIK3Cα; Breast cancer; 5DXT;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 204 条
[1]  
Abdel-Latif MK(2019)Study the solvation effect on 6-phenyl-2-thioxo-1,2-dihydropyridine-3-carbonitrile derivatives by TD- DFT calculations and molecular dynamics simulations J Mol Struct 1200 127056-1313
[2]  
Abd El-Mageed HR(2013)Aetio-pathogenesis of breast cancer Nig Med J 54 371-130
[3]  
Mohamed HS(2014)Novel synthesis of puriensanalougues and thieno[2,3-b] pyridine derivatives with anticancer and antioxidant activity J Pharm Res 8 1303-1376
[4]  
Mustafa FM(2016)Mixed bismuth(III) complexes with sulfur donor ligands Studies on synthetic, structural, thermal and biological properties J Therm Anal Calorim 124 117-14270
[5]  
Abdulkareem I(2008)Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype Clin Cancer Res 14 1368-2809
[6]  
Ahmed SA(2017)CDK8: a new breast cancer target Oncotarget 8 14269-170
[7]  
Ahmed OM(2016) pharmacokinetics and molecular docking of three leads isolated from Int J Pharm Sci 8 8-389
[8]  
Elgendy HS(2011)Molecular modeling study of checkpoint kinase 1 inhibitors by multiple docking strategies and prime/MM–GBSA calculation J Comput Chem 32 2800-61
[9]  
Chauhan HP(2017)CTLA-4 Genetic Variants (rs11571317 and rs3087243): Role in susceptibility and progression of breast cancer World J Oncol 8 162-4387
[10]  
Sapana J(2009)Identifying and characterizing binding sites and assessing druggability J Chem Info Mod 49 377-17